Construction of Early Warning Model for the New Psychoactive Substances Using in Adolescents

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-07-17

Study Completion Date

2023-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on the biological-psychology-sociological medicine pattern, this study aims to construction an early warning model of the New Psychoactive Substances (NPS) using for adolescents aged 14-35 years old. This study intends to obtain the data related to the behavioral expression of addiction susceptibility genes, adverse childhood experience, cognition, resistance and the use of NPS in adolescents by questionnaire survey (sample size: 200), and then use logistic regression and machine learning to construct an early warning model.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Construction of a Risk Screening Tool for New Psychoactive Substance Misuse Among Adolescents and Young Adults

NCT06714578

Drug Misuse Addiction

NOT_YET_RECRUITING

Individual Differences in Reward and Impulse Control

NCT01621607

Drug Addiction Vulnerability to Substance Addiction

COMPLETED

Adverse Adolescent Pathways to Substance Use

NCT06977178

Anxiety Adolescent Development Substance Use

RECRUITING NA

The Follow-up Study for the Patients of Illicit Substance Use Disorder

NCT04426565

Substance Use Disorders Illicit Drug Use

UNKNOWN NA

Evaluating Responses to Drug-Related Cues Versus Neutral Cues to Understand the Effects of Marijuana Craving - 1

NCT00218478

Marijuana Abuse

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on the biological-psychology-sociological medicine pattern, this study aims to construction an early warning model on the use of the New Psychoactive Substances using for adolescents aged 14-35 years old. This study intends to conduct a questionnaire survey (sample size 200) to obtain data related to the behavioral expression of addiction susceptibility genes, childhood adversity experience, cognition, resistance and the use of NPS in adolescents from different regions and different populations. Through data analysis, this study aims to get the weight of different risk factors on NPS use, and then use logistic regression and machine learning to construct an early warning model, so as to screen out high-risk groups. At the same time, the expert group was consulted to establish a risk early warning system to provide a basis for intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Addiction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Investigation Team

Questionnaires assessed adolescents aged 14-35 years old (including 14,25 years old) who agreed to participate in the study

Questionnaires

Intervention Type OTHER

Participants will be asked to complete the questionnaire including general demographic information, the cognition, resistance and use of NPS as well as the behavioral expression of addiction susceptibility genes and adverse childhood experience.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

Participants will be asked to complete the questionnaire including general demographic information, the cognition, resistance and use of NPS as well as the behavioral expression of addiction susceptibility genes and adverse childhood experience.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adolescents aged 14-35 (including 14,35 years old)
* Agree to participate in the studies

Exclusion Criteria

* Be diagnosed with psychological or mental illness
* People that are unconscious, emotionally unstable, or unable to communicate normally
* Patients with severe diseases

Minimum Eligible Age

14 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes